Trisomy 13 is associated with poor prognosis in idiopathic myelofibrosis with myeloid metaplasia

Leukemia and Lymphoma

Volumn 35, Issue 3-4, 1999, Pages 415-421

  Zojer, Niklas ^a,b   Meran, Johannes Gobertus ^a   Vesely, Michael ^a   Grüner, Helga ^a   Ackermann, Jutta ^a   Dellinger, Christian ^b   Zimmer Roth, Ilse ^a   Heinz, Renate ^a   Drach, Johannes ^a   Ludwig, Heinz ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b WILHELMINEN HOSPITAL   (Austria)

Author keywords

Cytogenetic changes; Fluorescence in situ hybridisation; Idiopathic myelofibrosis; Prognostic criteria; Trisomy 13

Indexed keywords

CYTARABINE;

AGED; ARTICLE; BLAST CELL; BLAST CELL CRISIS; BONE MARROW CELL; CASE REPORT; CELL STRUCTURE; CHROMOSOME 13; CHROMOSOME 9; CYTOGENETICS; DISEASE COURSE; FATALITY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; KARYOTYPE; MYELOFIBROSIS; MYELOID METAPLASIA; PRIORITY JOURNAL; PROGNOSIS; TRISOMY 13;

EID: 0032724480     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909145748     Document Type: Article

References (33)

1. Cervantes, F., Pereira, A., Esteve, J., Rafel, M., Cobo, F., Rozman, C. and Montserrat, E. (1997) Identification of "short-lived" versus "long-lived" patients at presentation of idiopathic myelofibrosis. Br J Haematol, 97, 635-640.
2. Dupriez, B., Morel, P., Demory, J.L., Lai, J.L., Simon, M., Plantier, I. and Bauters, F. (1996) Prognostic factors in agnogenic myeloid metaplasia: A report on 195 cases with a newscoring system. Blood, 88, 1013-1018.
3. Visani, G., Finelli, C., Castelli, U., Petti, M.C., Ricci, P., Vianelli, N., Gianni, L., Zuffa, E., Spiriti, A., Latagliata, R., Pileri, S., Magrini, U., Gugliotta, L., Morra, E., Bernasconi, C., Mandelli, F. and Tura, S. (1990) Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients. Br J Haematol, 75, 4-9.
4. Reilly, J.T., Snowden, J.A., Spearing, R.L., Fitzgerald, P.M., Jones, N., Watmore, A. and Potter, A. (1997) Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 cases. Br J Haematol, 98, 96-102.
5. Demory, J.L., Dupriez, B., Fenaux, P., Lai, J.L., Beuscart, R., Jouet, J.P., Deminatti, M. and Bauters, F. (1988) Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases. Blood, 72, 855-859.
6. Ferrara, F., Vicari, L., Festa, B., Di Noto, R., Pane, F., Sebastio, L. and Cimino, R. (1995) Trisomy 13 in a case of myelofibrosis with myeloid metaplasia in early blastic transformation. Haematologica, 80, 434-436.
7. Hsu, L.Y., Greenberg, M.L., Kohan, S. and Wittman, R. (1979) Trisomy 13 in bone marrow cells in acute myelocytic leukemia and myelofibrosis. Clinical Genetics, 15, 327-331.
8. Schweizer, D. (1980) Simultaneous fluorescent staining of R bands and specific heterochromatic regions (DA-DAPI bands) in human chromosomes. Cytogenet Cell Genetics, 27, 190-193.
9. Mitelman, F. ISCN. (1991) Guidelines for Cancer Cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature. Karger, Basel, Switzerland.
10. Drach, J., Angerler, J., Schuster, J., Rothermundt, C.A., Thalhammer, R., Haas, O.A., Jäger, U., Fiegl, M., Geissler, K., Ludwig, H. and Huber, H. (1995) Interphase fluorescence in situ hybridisation identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance. Blood, 86, 3915-3921.
11. Jack, F.R. and Summerfield, G.P. (1994) Long term remission of acute myeloid leukaemia with trilineage myelodysplasia treated solely with low dose cytarabine. Clin Lab Haematol, 16, 197-200.
12. Kawano, F., Nishimura, Y., Tsukamoto, A., Satoh, M., Sanada, I., Shido, T. (1992) Successful treatment with low dose Ara-C in de novo acute myeloid leukemia with trilineage myelodysplasia. Int J Hematol, 55, 101-102.
13. Kanamori, H., Tanabe, J., Koike, T., Hashimoto, Y., Matsuzaki, M., Kitamura, H., Motomura, S., Mohri, H., Ohkubo, T. (1994) Successful treatment of low dose cytosine arabinoside for acute myelofibrosis with immature myeloblasts (AML-M0). Am J Hematol, 46, 154-155.
14. Whitehead, S. and Geary, C.G. (1984) Low dose cytosine arabinoside to induce remission in acute myelofibrosis. Br J Haematol, 58, 375-376.
15. Reilly, J.T. and Dolan, G. (1991) Proposed classification for the myelodysplasia/myelofibrosis syndromes. Br J Haematol, 79, 653.
16. Guenova, M., Taskov, H. and Zechev, J. (1997) CD4+ acute undifferentiated leukaemia, propably early monoblastic type, developing in a patient with myelodysplastic syndrome and bone marrow fibrosis. Leuk Lymphoma, 26, 399-403.
17. Lambertenghi-Deliliers, G., Annaloro, C., Oriani, A. and Soligo. D. (1992) Myelodysplastic syndrome associated with bone marrow fibrosis. Leuk Lymphoma, 8, 51-55.
18. Martyre, M.C. (1995) TGF-β and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders. Leuk Lymphoma, 20, 39-44.
19. Martyre, M.C., Magdelenat, H., Bryckaert, H., Laine-Bidron, C. and Calvo, F. (1991) Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-β in patients with myelofibrosis with myeloid metaplasia. Br J Haematol, 77, 80-86.
20. Tefferi, A. and Silverstein, M.N. (1996) Current perspective in agnogenic myeloid metaplasia. Leuk Lymphoma, 22 (Suppl. 1). 169-171.
21. Kimura, A., Kawaishi, K., Nakata, Y., Hyodo, H., Kuramoto, A. and Satow, Y. (1995) Leukemic transformation of primary myelofibrosis: immunophenotype, genotype and growth characteristics of blast cells. Leuk Lymphoma, 19, 493-498.
22. Thiele, J., Kvasnicka, H.M., Werden, C., Zankovich, R., Diehl, V. and Fischer, R. (1996) Idiopathic primary osteomyelofibrosis: aclinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact. Leuk Lymphoma, 22, 303-317.
23. Reilly, J.T., Wilson, G., Barnett, D., Watmore, A. and Potter, A. (1994) Karyotypic and ras gene mutational analysis in idiopathic myelofibrosis. Br J Haematol, 88, 575-581.
24. Wang, J.C., Lang, H.D., Lichter, S., Weinstein, M. and Benn, P. (1992) Cytogenetic studies of bone marrow fibroblasts cultered from patients with myelofibrosis and myeloid metaplasia. Br J Haematol, 80, 184-188.
25. Mertens, F., Johansson, B., Heim, S., Kristofferson, U. and Mitelman, F. (1991) Karyotypic patterns in chronic myeloproliferative disorders: report on 74 cases and review of the literature. Leukemia, 5, 214-220.
26. Smadja, N., Krulik, M., de Gramont, A., Sirinelli, A., Brissaud, P., Dray, C., Audebert, A.A. and Debray, J. (1987) Cytogenetic studies in twelve patients with primary myelofibrosis and myeloid metaplasia. Cancer Genet Cytogenet, 24, 151-158.
27. Miller, J.B., Testa, J.R., Lindgren, V. and Rowley, J.D. (1985). The pattern and clinical significance of karyotypic abnormalities in patients with idiopathic and postpolycythemic myelofibrosis. Cancer, 55, 582-591.
28. Carbone, P., Barbata, G., Mirto, S., Marceno, R., Leone, S. and Granata, G. (1984) Cytogenetic studies in five patients with myelofibrosis and myeloid metaplasia. Cancer Genet Cytogenet, 12, 209-215.
29. Borgstrom, G.H., Knuutila, S., Ruutu, T., Pakkala, A., Lahtinen, R. and de la Chapelle, A. (1984) Abnormalities of chromosome 13 in myelofibrosis. Scand J Haematol, 33, 15-21.
30. Besa, E.C., Nowell, P.C., Geller, N.L. and Gardner, F.M. (1982) Analysis of the androgen response of 23 patients with agnogenic myeloid metaplasia: the value of chromosomal studies in predicating response and survival. Cancer, 49, 308-313.
31. Nowell, P., Jensen, J., Gardner, F., Murphy, S., Chaganti, R.S. and German, J. (1976) Chromosome studies in "preleukemia". III. Myelofibrosis. Cancer, 38, 1873-1881.
32. Döhner, H., Arthur, D.C., Ball, E.D., Sobol, R.E., Davey, F.R., Lawrence, D., Gordon, L., Patil, S.R., Surana, R.B., Testa, J.R., Verma, R.S., Schiffer, C.A., Wurster-Hill, D.H. and Bloomfield, C.D. (1990) Trisomy 13: A new recurring chromosome abnormality in acute leukemia. Blood, 76, 1614-1621.
33. Mehta, A.B., Bain, B.J., Fitchett, M., Sha, S. and Secker-Walker, L.M. (1998) Trisomy 13 and myeloid malignancy - characteristic blast cell morphology: a United Kingdom Cancer Cytogenetics Group survey. Br J Haematol, 101, 749-752.